<VariationArchive VariationID="142765" VariationName="NM_000535.7(PMS2):c.2117del (p.Lys706fs)" VariationType="Deletion" Accession="VCV000142765" Version="37" RecordType="classified" NumberOfSubmissions="17" NumberOfSubmitters="17" DateLastUpdated="2024-06-23" DateCreated="2016-05-29" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="152479" VariationID="142765">
      <GeneList>
        <Gene Symbol="PMS2" FullName="PMS1 homolog 2, mismatch repair system component" GeneID="5395" HGNC_ID="HGNC:9122" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7p22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="5970925" stop="6009106" display_start="5970925" display_stop="6009106" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="6012869" stop="6048736" display_start="6012869" display_stop="6048736" Strand="-" />
          </Location>
          <OMIM>600259</OMIM>
          <Haploinsufficiency last_evaluated="2015-11-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PMS2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-11-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PMS2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000535.7(PMS2):c.2117del (p.Lys706fs)</Name>
      <CanonicalSPDI>NC_000007.14:5982880:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7p22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="5982881" stop="5982881" display_start="5982881" display_stop="5982881" variantLength="1" positionVCF="5982880" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="6022512" stop="6022512" display_start="6022512" display_stop="6022512" variantLength="1" positionVCF="6022511" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K519fs</ProteinChange>
      <ProteinChange>K603fs</ProteinChange>
      <ProteinChange>K515fs</ProteinChange>
      <ProteinChange>K571fs</ProteinChange>
      <ProteinChange>K600fs</ProteinChange>
      <ProteinChange>K654fs</ProteinChange>
      <ProteinChange>K706fs</ProteinChange>
      <ProteinChange>K395fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.6022513del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.6022513del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.5982882del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.5982882del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008466.1" sequenceAccession="NG_008466" sequenceVersion="1" change="g.31226del">
            <Expression>NG_008466.1:g.31226del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000535.7" sequenceAccession="NM_000535" sequenceVersion="7" change="c.2117del" MANESelect="true">
            <Expression>NM_000535.7:c.2117del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000526.2" sequenceAccession="NP_000526" sequenceVersion="2" change="p.Lys706fs">
            <Expression>NP_000526.2:p.Lys706fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322003.2" sequenceAccession="NM_001322003" sequenceVersion="2" change="c.1712del">
            <Expression>NM_001322003.2:c.1712del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308932.1" sequenceAccession="NP_001308932" sequenceVersion="1" change="p.Lys571fs">
            <Expression>NP_001308932.1:p.Lys571fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322004.2" sequenceAccession="NM_001322004" sequenceVersion="2" change="c.1712del">
            <Expression>NM_001322004.2:c.1712del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308933.1" sequenceAccession="NP_001308933" sequenceVersion="1" change="p.Lys571fs">
            <Expression>NP_001308933.1:p.Lys571fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322005.2" sequenceAccession="NM_001322005" sequenceVersion="2" change="c.1712del">
            <Expression>NM_001322005.2:c.1712del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308934.1" sequenceAccession="NP_001308934" sequenceVersion="1" change="p.Lys571fs">
            <Expression>NP_001308934.1:p.Lys571fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322006.2" sequenceAccession="NM_001322006" sequenceVersion="2" change="c.1961del">
            <Expression>NM_001322006.2:c.1961del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308935.1" sequenceAccession="NP_001308935" sequenceVersion="1" change="p.Lys654fs">
            <Expression>NP_001308935.1:p.Lys654fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322007.2" sequenceAccession="NM_001322007" sequenceVersion="2" change="c.1799del">
            <Expression>NM_001322007.2:c.1799del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308936.1" sequenceAccession="NP_001308936" sequenceVersion="1" change="p.Lys600fs">
            <Expression>NP_001308936.1:p.Lys600fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322008.2" sequenceAccession="NM_001322008" sequenceVersion="2" change="c.1799del">
            <Expression>NM_001322008.2:c.1799del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308937.1" sequenceAccession="NP_001308937" sequenceVersion="1" change="p.Lys600fs">
            <Expression>NP_001308937.1:p.Lys600fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322009.2" sequenceAccession="NM_001322009" sequenceVersion="2" change="c.1712del">
            <Expression>NM_001322009.2:c.1712del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308938.1" sequenceAccession="NP_001308938" sequenceVersion="1" change="p.Lys571fs">
            <Expression>NP_001308938.1:p.Lys571fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322010.2" sequenceAccession="NM_001322010" sequenceVersion="2" change="c.1556del">
            <Expression>NM_001322010.2:c.1556del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308939.1" sequenceAccession="NP_001308939" sequenceVersion="1" change="p.Lys519fs">
            <Expression>NP_001308939.1:p.Lys519fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322011.2" sequenceAccession="NM_001322011" sequenceVersion="2" change="c.1184del">
            <Expression>NM_001322011.2:c.1184del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308940.1" sequenceAccession="NP_001308940" sequenceVersion="1" change="p.Lys395fs">
            <Expression>NP_001308940.1:p.Lys395fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322012.2" sequenceAccession="NM_001322012" sequenceVersion="2" change="c.1184del">
            <Expression>NM_001322012.2:c.1184del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308941.1" sequenceAccession="NP_001308941" sequenceVersion="1" change="p.Lys395fs">
            <Expression>NP_001308941.1:p.Lys395fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322013.2" sequenceAccession="NM_001322013" sequenceVersion="2" change="c.1544del">
            <Expression>NM_001322013.2:c.1544del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308942.1" sequenceAccession="NP_001308942" sequenceVersion="1" change="p.Lys515fs">
            <Expression>NP_001308942.1:p.Lys515fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322014.2" sequenceAccession="NM_001322014" sequenceVersion="2" change="c.2117del">
            <Expression>NM_001322014.2:c.2117del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308943.1" sequenceAccession="NP_001308943" sequenceVersion="1" change="p.Lys706fs">
            <Expression>NP_001308943.1:p.Lys706fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322015.2" sequenceAccession="NM_001322015" sequenceVersion="2" change="c.1808del">
            <Expression>NM_001322015.2:c.1808del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308944.1" sequenceAccession="NP_001308944" sequenceVersion="1" change="p.Lys603fs">
            <Expression>NP_001308944.1:p.Lys603fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_136154.1" sequenceAccession="NR_136154" sequenceVersion="1" change="n.2204del">
            <Expression>NR_136154.1:n.2204del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_161" sequenceAccession="LRG_161">
            <Expression>LRG_161:g.31226del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_161t1" sequenceAccession="LRG_161t1">
            <Expression>LRG_161t1:c.2117del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000535.7" sequenceAccession="NM_000535" sequenceVersion="7" change="c.2117delA" MANESelect="true">
            <Expression>NM_000535.7:c.2117delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA010865" DB="ClinGen" />
        <XRef Type="rs" ID="587782704" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000535.7(PMS2):c.2117del (p.Lys706fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV000132155" Version="8">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-02-17" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000535.7(PMS2):c.2117del (p.Lys706fs) AND not provided" Accession="RCV000221406" Version="15">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-04-08" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000535.7(PMS2):c.2117del (p.Lys706fs) AND Lynch syndrome" Accession="RCV000228992" Version="13">
        <ClassifiedConditionList TraitSetID="8777">
          <ClassifiedCondition DB="MedGen" ID="C4552100">Lynch syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000535.7(PMS2):c.2117del (p.Lys706fs) AND not specified" Accession="RCV000506059" Version="8">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-08-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000535.7(PMS2):c.2117del (p.Lys706fs) AND Hereditary nonpolyposis colorectal neoplasms" Accession="RCV000524458" Version="10">
        <ClassifiedConditionList TraitSetID="37727">
          <ClassifiedCondition DB="MedGen" ID="C0009405">Hereditary nonpolyposis colorectal neoplasms</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000535.7(PMS2):c.2117del (p.Lys706fs) AND Hereditary cancer" Accession="RCV000509483" Version="2">
        <ClassifiedConditionList TraitSetID="34074">
          <ClassifiedCondition DB="MedGen" ID="C1333600">Hereditary cancer</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000535.7(PMS2):c.2117del (p.Lys706fs) AND Lynch syndrome 4" Accession="RCV000709753" Version="7">
        <ClassifiedConditionList TraitSetID="2540">
          <ClassifiedCondition DB="MedGen" ID="C1838333">Lynch syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-22" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000535.7(PMS2):c.2117del (p.Lys706fs) AND Endometrial carcinoma" Accession="RCV001353753" Version="3">
        <ClassifiedConditionList TraitSetID="1474">
          <ClassifiedCondition DB="MedGen" ID="C0476089">Endometrial carcinoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000535.7(PMS2):c.2117del (p.Lys706fs) AND Hereditary nonpolyposis colon cancer" Accession="RCV002307406" Version="1">
        <ClassifiedConditionList TraitSetID="53926">
          <ClassifiedCondition DB="MedGen" ID="C1333990">Hereditary nonpolyposis colon cancer</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-22" NumberOfSubmissions="17" NumberOfSubmitters="17" DateCreated="2016-05-29" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21376568</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23012243</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24362816</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25856668</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26110232</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26681312</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26921362</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27001570</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27476653</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28135145</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30322717</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30680046</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31992580</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32885271</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1474" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1151" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Endometrial carcinoma</ElementValue>
                <XRef ID="Endometrial+cancer/8312" DB="Genetic Alliance" />
                <XRef ID="HP:0012114" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0002447" DB="MONDO" />
                <XRef ID="254878006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Endometrial carcinoma, somatic</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="AHRQ, 2013">
                <URL>https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf</URL>
                <CitationText>Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="SGO, 2014">
                <ID Source="PubMed">24905773</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="SGO, 2021">
                <ID Source="PubMed">33516529</ID>
              </Citation>
              <Citation Type="general" Abbrev="SGO, 2021">
                <ID Source="PubMed">33451724</ID>
              </Citation>
              <Citation Type="general" Abbrev="SGO, 2014">
                <ID Source="PubMed">24929052</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/dg42</URL>
                <CitationText>UK NICE Diagnostics Guidance DG42, Testing strategies for Lynch syndrome in people with endometrial cancer, 2020</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Uterine Neoplasms, 2024</CitationText>
              </Citation>
              <XRef ID="C0476089" DB="MedGen" />
              <XRef ID="MONDO:0002447" DB="MONDO" />
              <XRef Type="MIM" ID="608089" DB="OMIM" />
              <XRef Type="primary" ID="HP:0012114" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8777" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14688" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Lynch syndrome</ElementValue>
                <XRef ID="2622" DB="GeneTests" />
                <XRef ID="Hereditary+Non-Polyposis+Colorectal+Cancer+%28HNPCC%29/3371" DB="Genetic Alliance" />
                <XRef ID="MONDO:0005835" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000530202" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551463" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520867" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000316595" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552440" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591173" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000322202" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520394" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528915" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551459" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520868" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558908" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520392" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515821" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000321105" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515534" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522224" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512828" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520080" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569958" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512403" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518999" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552245" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520871" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552184" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558503" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515774" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528930" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528534" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519150" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591263" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520872" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520030" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561860" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551464" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562151" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522225" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332519" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528914" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000325623" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530028" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528529" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520869" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519254" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568362" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000527981" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522278" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000604264" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518997" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568365" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552183" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551461" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9905" />
                <XRef ID="9905" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743612</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCRS, 2001">
                <ID Source="PubMed">11598466</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="AMA/NCHPEG, 2012">
                <URL>http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf</URL>
              </Citation>
              <Citation Type="practice guideline" Abbrev="SGO, 2014">
                <URL>https://www.sgo.org/clinical-practice/guidelines/screening-for-lynch-syndrome-in-endometrial-cancer</URL>
                <CitationText>Society of Gynecologic Oncology (SGO) Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="MSTF, 2014">
                <ID Source="PubMed">25070057</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2013">
                <ID Source="pmc">3585492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/ESMO, 2015">
                <ID Source="PubMed">25452455</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24310308</ID>
              </Citation>
              <Citation Type="general" Abbrev="Mork et al., 2015">
                <ID Source="PubMed">25711197</ID>
              </Citation>
              <Citation Type="general" Abbrev="Dutch SCG, 2013">
                <ID Source="PubMed">23535968</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="Mallorca group, 2013">
                <ID Source="PubMed">23408351</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAPS, 2020">
                <ID Source="PubMed">31672839</ID>
                <ID Source="pmc">7295005</ID>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Goldberg et al, 2019">
                <ID Source="PubMed">31302137</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/dg42</URL>
                <CitationText>UK NICE Diagnostics Guidance DG42, Testing strategies for Lynch syndrome in people with endometrial cancer, 2020</CitationText>
              </Citation>
              <XRef ID="144" DB="Orphanet" />
              <XRef ID="C4552100" DB="MedGen" />
              <XRef ID="MONDO:0005835" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="34074" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="36762" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer</ElementValue>
                <XRef ID="CMGVARID00285" DB="Centre for Mendelian Genomics, University Medical Centre Ljubljana" />
              </Name>
              <XRef ID="C1333600" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="53926" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="53477" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary nonpolyposis colorectal cancer</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial nonpolyposis colon cancer</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary nonpolyposis colon cancer</ElementValue>
                <XRef ID="MONDO:0018630" DB="MONDO" />
                <XRef ID="155018" DB="NCBI for submitter" />
                <XRef ID="315058005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Nonpolyposis Colorectal Cancer Syndrome</ElementValue>
                <XRef ID="C120083" DB="NCI" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HNPCC</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000558908" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568362" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530028" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596791" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000325623" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332533" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568365" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520080" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Lynch-Syndrome.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, MLH1, MSH2, MSH6, PMS2, EPCAM Pathogenic Variants, Lynch Syndrome (Hereditary Non-polyposis Colon Cancer [HNPCC]), 2019</CitationText>
              </Citation>
              <XRef ID="443909" DB="Orphanet" />
              <XRef ID="C1333990" DB="MedGen" />
              <XRef ID="MONDO:0018630" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS120435" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="37727" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38245" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary nonpolyposis colorectal neoplasms</ElementValue>
                <XRef ID="D003123" DB="MeSH" />
              </Name>
              <XRef ID="C0009405" DB="MedGen" />
              <XRef ID="D003123" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2540" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10524" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Lynch syndrome 4</ElementValue>
                <XRef ID="MONDO:0013699" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colorectal cancer, hereditary nonpolyposis, type 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary non-polyposis colorectal cancer, type 4</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LYNCH4</ElementValue>
                <XRef Type="MIM" ID="614337" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528529" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510418" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512403" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528914" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501424" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512402" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514731" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512645" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15791" />
                <XRef ID="15791" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Lynch-Syndrome.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, MLH1, MSH2, MSH6, PMS2, EPCAM Pathogenic Variants, Lynch Syndrome (Hereditary Non-polyposis Colon Cancer [HNPCC]), 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/dg42</URL>
                <CitationText>UK NICE Diagnostics Guidance DG42, Testing strategies for Lynch syndrome in people with endometrial cancer, 2020</CitationText>
              </Citation>
              <XRef ID="144" DB="Orphanet" />
              <XRef ID="C1838333" DB="MedGen" />
              <XRef ID="MONDO:0013699" DB="MONDO" />
              <XRef Type="MIM" ID="614337" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1174478" SubmissionDate="2017-08-22" DateLastUpdated="2017-10-16" DateCreated="2017-10-16">
        <ClinVarSubmissionID localKey="genomeconnect_15480_622" localKeyIsSubmitted="1" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000607287" DateUpdated="2017-10-16" DateCreated="2017-10-16" Type="SCV" Version="1" SubmitterName="GenomeConnect, ClinGen" OrgID="506185" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">40</Age>
              <Age Type="maximum" age_unit="years">49</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>male</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
                <Trait Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Hereditary nonpolyposis colon cancer</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <Purpose>validation</Purpose>
              <Description>Sanger Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Gene Panel Sequencing</Attribute>
              </MethodAttribute>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2015-10-16" integerValue="1197">Myriad Genetic Laboratories, Inc.,Myriad Genetic Laboratories, Inc.</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the intestine</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0002242" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Colon cancer</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0003003" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.5:c.2117del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1333600" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GenomeConnect_noassembly_81817</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1571103" SubmissionDate="2018-01-29" DateLastUpdated="2016-05-29" DateCreated="2016-05-29">
        <ClinVarSubmissionID localKey="NM_000535.5:c.2117delA|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000806152" DateUpdated="2016-05-29" DateCreated="2016-05-29" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-11-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.5:c.2117delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3589995</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1637598" SubmissionDate="2018-06-14" DateLastUpdated="2018-10-14" DateCreated="2018-10-14">
        <ClinVarSubmissionID localKey="NM_000535.5:c.2117delA|OMIM:614337" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000840045" DateUpdated="2018-10-14" DateCreated="2018-10-14" Type="SCV" Version="1" SubmitterName="Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine" OrgID="500199" OrganizationCategory="laboratory" OrgAbbreviation="HGSC-CL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.2117delA (p.Lys706Serfs*19) variant has been in a 53 y/o female with colorectal cancer in the transverse colon [PMID 5856668], an also detected in a family with Lynch syndrome [PMID 26110232]. This variant was also recently detected at the homozygous state in 2 young siblings with recurrent gliobalstoma multiforme and NF1 features [PMID 27001570]. Treatment with the anti-programmed death-1 inhibitor nivolumab resulted in clinically significant responses and a profound radiologic response. This variant was not observed in the ExAC population database nor in our patient cohort. This 1 bp deletion is located in exon 12, and leads to a frameshift and a premature stop codon. This variant is expected to result in a loss of function of the protein and is thus classified as pathogenic. Pathogenic variant in the PMS2 gene are considered medically actionable [ACMG59, PMID 27854360]</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.5:c.2117delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614337" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4151980</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="516692" SubmissionDate="2022-04-27" DateLastUpdated="2023-03-04" DateCreated="2016-05-29">
        <ClinVarSubmissionID localKey="GDXSV:226306" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000279149" DateUpdated="2023-03-04" DateCreated="2016-05-29" Type="SCV" Version="13" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Observed with a pathogenic variant on the opposite allele (in trans) and in the homozygous state in patients with Constitutional Mismatch Repair Deficiency syndrome in the published literature (Adam 2016, Bouffet 2016); Observed in patients with Lynch-related cancers and tumor studies consistent with pathogenic variants in this gene (Goodenberger 2016, Suerink 2015, Yurgelun 2017, Wang 2020); Truncating variants in this gene are considered pathogenic by a well-established clinical consortium and/or database; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26681312, 25856668, 26110232, 28514183, 28135145, 28152038, 23012243, 27001570, 27476653, 30322717, 32885271, 30787465, 31992580, 31447099)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:48957</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.5:c.2117del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_103_20220427054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_62_20211022152658</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="540329" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2016-07-01">
        <ClinVarSubmissionID localKey="209350|MedGen:C0009405" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000285105" DateUpdated="2024-02-20" DateCreated="2016-07-01" Type="SCV" Version="11" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21376568</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24362816</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23012243</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25856668</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26110232</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26681312</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27001570</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27476653</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28135145</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30322717</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30680046</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys706Serfs*19) in the PMS2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PMS2 are known to be pathogenic (PMID: 21376568, 24362816). The frequency data for this variant in the population databases (gnomAD) is considered unreliable due to the presence of homologous sequence, such as pseudogenes or paralogs, in the genome. This premature translational stop signal has been observed in individual(s) with constitutional mismatch repair deficiency, Lynch syndrome, and/or ovarian cancer (PMID: 23012243, 25856668, 26110232, 26681312, 27001570, 27476653, 28135145, 30322717, 30680046). ClinVar contains an entry for this variant (Variation ID: 142765). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.6022512del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0009405" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7857067" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000535.7:c.2117del|OMIM:614337" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004207858" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.7:c.2117del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614337" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1168582" SubmissionDate="2017-06-30" DateLastUpdated="2017-09-30" DateCreated="2017-09-30">
        <ClinVarSubmissionID localKey="118558|MedGen:CN169374" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000604886" DateUpdated="2017-09-30" DateCreated="2017-09-30" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" OrgAbbreviation="ARUP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-08-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/w2yp3qyt/arup_molecular_germline_variant_investigation_process.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Lys706fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.5:c.2117delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN169374" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2830276</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2832518" SubmissionDate="2020-09-15" DateLastUpdated="2020-10-02" DateCreated="2020-10-02">
        <ClinVarSubmissionID localKey="CS-19-71209|OMIM:614337" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001434294" DateUpdated="2020-10-02" DateCreated="2020-10-02" Type="SCV" Version="1" SubmitterName="Division of Medical Genetics, University of Washington" OrgID="507302" OrganizationCategory="laboratory" OrgAbbreviation="DMG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant leads to a translational frameshift and the introduction of a premature termination codon 19 residues downstream. The variant transcript is predicted to be unstable and degraded by nonsense-mediated decay. Loss of expression of one allele of PMS2 is a well-established mechanism of disease for Lynch syndrome. This variant has been reported in the literature in an individual with colon cancer (Leiter 1965) and a family with Lynch syndrome (Suerink 2016). It has also been reported in individuals with constitutional mismatch repair deficiency syndrome (Bouffet 2016, Adam 2016). This variant is not present in population databases (https://gnomad.broadinstitute.org/). Thus, this variant is interpreted as pathogenic. PM2; PVS1; PM3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.7:c.2117delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614337" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER_CHARM</StudyName>
        <StudyDescription>NIH-funded Cancer Health Assessments Reaching Many Study</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB8063199</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2857684" SubmissionDate="2020-10-23" DateLastUpdated="2020-11-28" DateCreated="2020-11-28">
        <ClinVarSubmissionID localKey="report_configuration_variant_id:516713" />
        <ClinVarAccession Accession="SCV001447296" DateUpdated="2020-11-28" DateCreated="2020-11-28" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen" OrgID="506385" OrganizationCategory="laboratory" OrgAbbreviation="IMGAG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal unknown</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SampleLocalID">DX203097</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="C" referenceAllele="CT" start="6022511" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1149389" SubmissionDate="2021-03-31" DateLastUpdated="2021-04-13" DateCreated="2017-04-16">
        <ClinVarSubmissionID localKey="chr7:6022510-6022512:e6d20c0851492a806943d1f99dbdd921-ENDOMETRIAL" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000592945" DateUpdated="2021-04-13" DateCreated="2017-04-16" Type="SCV" Version="2" SubmitterName="Department of Pathology and Laboratory Medicine, Sinai Health System" OrgID="506152" OrganizationCategory="laboratory" OrgAbbreviation="PLM-SHS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506759" SubmitterName="Franklin by Genoox" Type="secondary" OrganizationCategory="other" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The PMS2 p.Lys706SerfsX19 variant was identified in 5 of 90280 proband chromosomes (frequency: 0.00005) from American individuals or families with CRC and unexplained adenomatous polyposis (Yurgelun 2017, Espenschied 2017, Adam 2016). In one study looking at glioblastomas, this variant was identified in homozygous state in 2 affected siblings with characteristics of CMMRD (Constitutional Mismatch Repair Deficiency) exhibiting cafâˆšÂ©-au-lait spots and neurofibromatosis type 1 and glioblastoma tumors showing a higher mutation load than sporadic pediatric and adult gliomas (Bouffet 2016). In another study looking at unexplained FAP, 1 individual carried the variant with a co-occurring pathogenic PMS2 variant (c.1A&gt;T [p.Met1?), confirming CMMRD (Adam 2016). The variant was also identified in dbSNP (ID: rs587782704) â€šÃ„ÃºWith Pathogenic alleleâ€šÃ„Ã¹, ClinVar (classified pathogenic by Ambry Genetics, GeneDx and Invitae), Clinvitae (3x), COGR (classified as pathogenic by 1 clinical laboratory), Insight Colon Cancer Gene Variant Database, and Insight Hereditary Tumors Database. The variant was not identified in Cosmic, MutDB, Zhejiang Colon Cancer Database, Mismatch Repair Genes Variant Database, the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project or the Exome Aggregation Consortium (August 8th 2016). The p.Lys706SerfsX19 variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 706 and leads to a premature stop codon 19 codons downstream. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the PMS2 gene are an established mechanism of disease in Lynch syndrome and is the type of variant expected to cause the disorder. In summary, based on the above information this variant meets our laboratoryâ€šÃ„Ã´s criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="4" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="C" referenceAllele="CT" start="6022511" stop="6022512" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0002447" />
          </Trait>
        </TraitSet>
        <StudyName>The Canadian Open Genetics Repository (COGR)</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9371647</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4050561" SubmissionDate="2022-01-25" DateLastUpdated="2022-01-29" DateCreated="2022-01-29">
        <ClinVarSubmissionID localKey="NM_000535.5(PMS2):c.2117del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002067456" DateUpdated="2022-01-29" DateCreated="2022-01-29" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>DNA sequence analysis of the PMS2 gene demonstrated a 1 base pair deletion in exon 12, c.2117del. This pathogenic sequence change results in an amino acid frameshift and creates a premature stop codon 18 amino acids downstream of the mutation, p.Lys706Serfs*19. This pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated PMS2 protein with potentially abnormal function. This sequence change has not been reported in population databases (gnomAD, ExAC). The p.Lys706Serfs*19 change has been reported in individuals with Lynch syndrome (PMID: 26110232, 23012243, 25856668, 28135145), constitutional mismatch repair deficiency syndrome (CMMR-D) (PMID: 27001570, 27476653), and ovarian cancer (PMID: 26681312). Additionally, other frameshift deletions downstream of this sequence change in PMS2 have been described in patients with Lynch syndrome (PMIDs: 22081473, 24689082). These collective evidences suggest this is a pathogenic sequence change, however functional studies have not been performed to prove this conclusively.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.5:c.2117del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10987855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1363681" SubmissionDate="2022-11-10" DateLastUpdated="2022-11-19" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="NM_000535.6:c.2117delA|MedGen:C1333990" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000697329" DateUpdated="2022-11-19" DateCreated="2017-12-26" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25856668</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27476653</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27001570</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26110232</ID>
          </Citation>
          <Comment>Variant summary: PMS2 c.2117delA (p.Lys706SerfsX19) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 226056 control chromosomes (gnomAD). c.2117delA has been reported in the literature in multiple individuals affected with Hereditary Nonpolyposis Colorectal Cancer (e.g. Goodenberger_2015, Suerink_2016), while it was also reported in a 64 year-old unaffected individual (Goodenberger_2015). Furthermore, the variant was detected in homozygous siblings and in another compound heterozygous individual affected with constitutional MMR deficiency (Adam_2016, Bouffet_2016). These data indicate that the variant is very likely to be associated with disease. Ten ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.6:c.2117delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1333990" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
          <SubmissionName>SUB12274151</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7806401" SubmissionDate="2023-11-24" DateLastUpdated="2023-12-02" DateCreated="2023-12-02">
        <ClinVarSubmissionID localKey="NM_000535.7:c.2117del|OMIM:614337" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004171642" DateUpdated="2023-12-02" DateCreated="2023-12-02" Type="SCV" Version="1" SubmitterName="Zotz-Klimas Genetics Lab, MVZ Zotz Klimas" OrgID="507243" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-24">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.7:c.2117del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614337" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13998455</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7828522" SubmissionDate="2023-12-21" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="10003412|OMIM:614337" />
        <ClinVarAccession Accession="SCV004187682" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="7" alternateAllele="C" referenceAllele="CT" start="6022511" stop="6022512" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">10003412</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614337" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104645</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8044548" SubmissionDate="2024-01-25" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkZhkEQDnbS4U2fQgjZotDW0|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004359548" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Color Diagnostics, LLC DBA Color Health" OrgID="505849" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23012243</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25856668</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26110232</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26681312</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27001570</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27476653</ID>
          </Citation>
          <Comment>This variant deletes 1 nucleotide in exon 12 of the PMS2 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. An RNA study has indicated that the variant transcript is not stably expressed (PMID: 26110232). This variant has been reported in individuals affected with Lynch syndrome (PMID: 23012243, 25856668, 26110232) and ovarian cancer (PMID: 26681312), This variant also have been detected in compound heterozygosity and in homozygosity in two individuals affect with constitutional mismatch repair deficiency syndrome (PMID: 27001570, 27476653). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of PMS2 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.7:c.2117del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14171678</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1393753" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2018-04-09">
        <ClinVarSubmissionID localKey="72388876|Orphanet:ORPHA144" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000712647" DateUpdated="2024-04-20" DateCreated="2018-04-09" Type="SCV" Version="3" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26110232</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25856668</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23012243</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27001570</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26681312</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30322717</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31992580</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32885271</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28135145</ID>
          </Citation>
          <Comment>The p.Lys706SerfsX19 variant in PMS2 has been reported in at least 6 individuals with Lynch syndrome-associated cancers (Vaughn 2013 PMID: 23012243, Goodenberger 2015 PMID: 25856668, Susswein 2016 PMID: 26681312, Yurgelun 2017 PMID: 28135145, Carter 2018 PMID: 30322717, Lerner-Ellis 2020 PMID: 32885271, Wang 2020 PMID: 31992580), as well as in 4 individuals from a family included in a study of pre-symptomatic and symptomatic variant carriers (Suerink 2016 PMID: 26110232, no clinical details provided). It has also been reported in the homozygous state in two siblings with constitutional mismatch repair deficiency syndrome (Bouffet 2016 PMID: 27001570). This variant has been reported by other clinical laboratories in ClinVar (Variation ID: 14276) and was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 706 and leads to a premature termination codon 19 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the PMS2 gene is an established disease mechanism in autosomal dominant Lynch syndrome. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant Lynch syndrome. ACMG/AMP Criteria applied: PVS1, PM2_Supporting, PS4_Moderate.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000535.7:exon 12</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.14:g.5982881delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA144" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
          <SubmissionName>SUB5348979</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="305744" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2014-08-06">
        <ClinVarSubmissionID localKey="a9405|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000187229" DateUpdated="2024-05-01" DateCreated="2014-08-06" Type="SCV" Version="8" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25856668</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26110232</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26921362</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27001570</ID>
          </Citation>
          <Comment>The c.2117delA pathogenic mutation, located in coding exon 12 of the PMS2 gene, results from a deletion of one nucleotide at nucleotide position 2117, causing a translational frameshift with a predicted alternate stop codon (p.K706Sfs*19). This alteration has been reported in an individual diagnosed with transverse colon cancer at the age of 53, whose tumor was MSI-H, as well as in a healthy individual at the age of 64 (Goodenberger ML et al. Genet. Med. 2016 Jan;18:13-9). It has also been reported in multiple individuals from a Lynch syndrome family (Suerink M et al. Genet. Med. 2016 Apr;18:405-9). In addition, two siblings with diagnoses of constitutional mismatch repair (CMMRD) syndrome, both with recurrent diagnoses of glioblastoma multiforme, as well as caf&amp;eacute;-au-lait spots, were found to be homozygous for this alteration (Bouffet E et al. J. Clin. Oncol. 2016 Jul;34:2206-11). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.5:c.2117delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1393753" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA144" MappingRef="Orphanet">
        <MedGen CUI="C4552100" Name="Lynch syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7806401" TraitType="Disease" MappingType="XRef" MappingValue="614337" MappingRef="OMIM">
        <MedGen CUI="C1838333" Name="Lynch syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174478" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of the intestine" MappingRef="Preferred">
        <MedGen CUI="C4316788" Name="Abnormal intestine morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="540329" TraitType="Disease" MappingType="XRef" MappingValue="C0009405" MappingRef="MedGen">
        <MedGen CUI="C0009405" Name="Hereditary nonpolyposis colorectal neoplasms" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857684" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174478" TraitType="Disease" MappingType="XRef" MappingValue="C1333600" MappingRef="MedGen">
        <MedGen CUI="C1333600" Name="Hereditary cancer" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1363681" TraitType="Disease" MappingType="XRef" MappingValue="C1333990" MappingRef="MedGen">
        <MedGen CUI="C1333990" Name="Hereditary nonpolyposis colon cancer" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="305744" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1571103" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7857067" TraitType="Disease" MappingType="XRef" MappingValue="614337" MappingRef="OMIM">
        <MedGen CUI="C1838333" Name="Lynch syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4050561" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1168582" TraitType="Disease" MappingType="XRef" MappingValue="CN169374" MappingRef="MedGen">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8044548" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2832518" TraitType="Disease" MappingType="XRef" MappingValue="614337" MappingRef="OMIM">
        <MedGen CUI="C1838333" Name="Lynch syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1637598" TraitType="Disease" MappingType="XRef" MappingValue="614337" MappingRef="OMIM">
        <MedGen CUI="C1838333" Name="Lynch syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="516692" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1149389" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0002447" MappingRef="MONDO">
        <MedGen CUI="C0476089" Name="Endometrial carcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1174478" TraitType="Finding" MappingType="Name" MappingValue="Colon cancer" MappingRef="Preferred">
        <MedGen CUI="C0007102" Name="Colon cancer" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7828522" TraitType="Disease" MappingType="XRef" MappingValue="614337" MappingRef="OMIM">
        <MedGen CUI="C1838333" Name="Lynch syndrome 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

